Skip to main content

Minimally Invasive Surgical Instruments Market | Rapid Advancements In New Technologies To Boost The Market

A minimally invasive surgical (MIS) procedure refers to the surgery performed with minute incisions in the body; for instance, plaque blockages in the arteries of the heart and other vessel walls of peripheral organs, such as lower extremities, neck, kidneys, and brain. The principal advantage of these procedures over surgery is short recovery time, small scars, low risk of infection, less bleeding, and shorter hospital stays.

The MIS market is expected to grow at a fast rate with a CAGR of 8.2% and is expected to reach $35.5 billion. The surgical instruments segment commanded the larger share; i.e. 38.4%, of the global minimally invasive surgical devices market. This growth has been primarily attributed to the increased usage of these devices and instruments in MIS procedures. Devices such as guiding catheters and guidewires as well as balloons have been widely used in interventional angioplasty and peripheral extremity MIS procedures. Numerous innovations in the technologies of devices such as balloons have added to the growth in the market.


The global minimally invasive surgical devices market is classified into handheld instruments, guiding devices, inflation systems, auxiliary devices, ultrasound, X-ray, CT & MRI imaging, visualization systems, electrosurgical devices and robotic systems. Newer innovations and rapidly evolving technologies in the field of surgical devices used in minimally invasive procedures will drive the MIS market. Imaging and diagnostic technologies such as ultrasound involving IVUS (intravascular ultrasound) and OCT (optical coherence tomography) have considerably changed the usage patterns of diagnostic techniques. These device systems show significant promise in terms of guidance in treatment and diagnosis. OCT has helped in high-resolution imaging of atherosclerotic plaque erosions that were previously not possible with imaging systems, thereby contributing to a boosting growth to the market.

North America constitutes the biggest market for the MIS devices and technologies, followed by Europe, and Asia. Pricing and reimbursement issues in certain regions of the world such as European and Asian countries have hampered the growth of the MIS devices market. Budgets constraints in hospitals force physicians to re-use accessory devices in MIS procedures, due to lack of reimbursements.

Major players in the minimally invasive surgery devices and imaging & visualization systems market include Intuitive Surgical (U.S.), GE Healthcare (U.K.), Philips (The Netherlands), Siemens (Germany) and Covidien (U.S.).

The various devices used in MIS procedures are categorized into:
  • Surgical Devices – Handheld instruments, mechanical cutters, auxiliary devices, guiding devices (guidewires and guiding catheters) and inflation systems (balloons and balloon inflation devices)
  • Electrosurgical Devices – Electrosurgical generators, vessel sealing instruments, electrocautery devices and accessories
  • Imaging Devices – Ultrasound, CT, MRI, X-ray devices and visualization systems
  • Robotic Systems – da-Vinci, ROBODOC, RIO, Neuromate and SpineAssist
This minimally invasive surgical devices and imaging systems report forecasts the size of the market over a period of five years (2011-2016). It also discusses the key market drivers, restraints and opportunities of the market and its sub markets. The report’s ‘Strategy’ section sketches the competitive landscape, featuring about 32 company profiles.


Article Credit: Healthcare DC

Comments

Popular posts from this blog

Dental Bone Graft Substitutes Market worth $664.3 Million by 2021

According to a new market research report  " Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" , published by MarketsandMarkets, The global market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts. This report mainly considers four type

Ostomy Care Accessories Market

The global ostomy care accessories market is projected to reach USD 2.99 billion by 2022 from USD 2.40 billion in 2017, at the CAGR of 4.5%. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of this market. The ostomy care accessories market is expected to grow at the highest CAGR during the forecast period owing to the growing skin problems due to frequent removal and re-application of skin barrier of ostomy bags and rising awareness about care of peristomal skin. Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=267183143 By system, the ostomy bags market is segmented into one-piece, two-piece, and skin barrier. Two-piece bags are expected to hold the

Cartilage Regeneration Market | Growth and Analysis, Industry Trends, Size, Shares, Forecast

The global  cartilage regeneration market  is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of cartilage regeneration market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the market. The cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share i